Philips releases upgrade package for radiology and echo platforms
Philips has released a package of enhancements and new system configurations for its ultrasound portfolio. The upgrades, known collectively as Vision 2005, include new capabilities for the company’s latest radiology and cardiology platforms.
Philips has released a package of enhancements and new system configurations for its ultrasound portfolio. The upgrades, known collectively as Vision 2005, include new capabilities for the company's latest radiology and cardiology platforms.
Highlights include new pediatric cardiology capabilities and enhanced vascular capabilities on the iE33 (cardiology) system, cardiology capabilities and photo-quality 3D fetal imaging on the iU22 (radiology) system, and oncart and offcart upgrades to QLAB Quantification Software on both platforms.
Philips' iE33 (intelligent echo) system and iU22 (intelligent ultrasound) system support traditional 2D as well as 3D and 4D visualization. They use advanced transducer technology (xMATRIX), crystals (PureWave), user-centered ergonomics, and volumetric quantification. Several enhancements build on these core technologies.
On the iE33, 3DQ Advanced software is used to measure the contractility of the heart to help determine which patients are the best candidates for cardiac resynchronization therapy (CRT). Vision 2005 introduces 3D synchronicity indices that can quantify cardiac dyssynchrony and, thereby, standardize 3D evaluation for CRT. The pediatric cardiology package includes a new multiplanar transesophegeal echo transducer optimized for use during pediatric surgery.
On the iU22, Vision 2005 provides faster volume rates and better 4D image quality by incorporating Philips' SonoCT compound imaging. The X3-1 xMATRIX array transducer enables real-time volume-rendered imaging for general viewing as well as cardiac applications. Other enhancements include the ability to measure intima media thickness, an indicator of early atherosclerosis.
The 3D Viewer allows the review and display of 3D data sets and multiplanar reconstructions similar to those used in MR and CT. Analysis tools allow the review of contrast loops and creation of microvascular imaging files that visualize blood flow in extremely small vessels. Cardiac quantification of 3D data sets and strain quantification are also available.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
